Table 2. Correlation of EHF expression to clinicopathological features in PDAC.
Parameters | EHF (n) | χ2 | P | Spearman r | |
---|---|---|---|---|---|
Low | High | ||||
Age (yr) | |||||
<60 | 35 | 12 | 0.306 | 0.580 | 0.056 |
≥60 | 34 | 15 | |||
Sex | |||||
Male | 36 | 16 | 0.392 | 0.531 | −0.064 |
Female | 33 | 11 | |||
Histological grade | |||||
G1, G2 | 40 | 23 | 6.371 | 0.012a | −0.258 |
G3 | 29 | 4 | |||
pTNM stage | |||||
IA, IB | 14 | 11 | 4.214 | 0.040a | −0.210 |
IIA, IIB | 55 | 16 | |||
CD8 | |||||
≤20/HP | 53 | 10 | 13.609 | 0.000a | 0.377 |
>20/HP | 16 | 17 | |||
T reg cell | |||||
≤20/HP | 27 | 20 | 9.483 | 0.002a | −0.314 |
>20/HP | 42 | 7 | |||
MDSC | |||||
≤10/HP | 17 | 13 | 4.993 | 0.025a | −0.228 |
>10/HP | 52 | 14 |
Data were based on tissue IF assay. Statistical data on EHF expression in relation to clinic-histopathologic features for surgical PDAC specimens. P values were calculated using the χ2 test.
Statistically significant (P < 0.05).